Jarrod Longcor Biography and Net Worth

Mr. Longcor brings to Cellectar Biosciences, Inc. more than 20 years of pharmaceutical and biotech experience and was previously the Chief Business Officer for Avillion LLP. In this role, he was responsible for executing the company’s unique co-development partnership strategy. Prior to Avillion, Jarrod was the Vice President of Corporate Development for Rib-X Pharmaceuticals, Inc. (now Melinta Therapeutics) where he was responsible for identifying and concluding several critical collaborations for the company, including a major discovery collaboration with Sanofi Aventis valued over $700M. Prior to Rib-X, Mr. Longcor has held key positions in several small to midsized biotech companies where he was responsible for business development, strategic planning and operations. Jarrod holds a Bachelor of Science degree from Dickinson College, a Master of Science from Boston University School of Medicine and a Master of Business Administration from Saint Joseph’s University’s Haub School of Business.

What is Jarrod Longcor's net worth?: The estimated net worth of Jarrod Longcor is at least $48.52 thousand as of July 2nd, 2025. Mr. Longcor owns 12,768 shares of Cellectar Biosciences stock worth more than $48,518 as of December 4th. This net worth estimate does not reflect any other assets that Mr. Longcor may own. Additionally, Mr. Longcor receives an annual salary of $854,240.00 as COO at Cellectar Biosciences. Learn More about Jarrod Longcor's net worth.
How old is Jarrod Longcor?: Mr. Longcor is currently 51 years old. There are 4 older executives and no younger executives at Cellectar Biosciences. The oldest executive at Cellectar Biosciences is Mr. James V. Caruso, President, CEO & Director, who is 65 years old. Learn More on Jarrod Longcor's age.
What is Jarrod Longcor's salary?: As the COO of Cellectar Biosciences, Inc., Mr. Longcor earns $854,240.00 per year. The highest earning executive at Cellectar Biosciences is Mr. James V. Caruso, President, CEO & Director, who commands a salary of $1,140,000.00 per year. Learn More on Jarrod Longcor's salary.
How do I contact Jarrod Longcor?: The corporate mailing address for Mr. Longcor and other Cellectar Biosciences executives is 100 CAMPUS DRIVE, FLORHAM PARK NJ, 07932. Cellectar Biosciences can also be reached via phone at (608) 441-8120 and via email at [email protected]. Learn More on Jarrod Longcor's contact information.
Has Jarrod Longcor been buying or selling shares of Cellectar Biosciences?: Jarrod Longcor has not been actively trading shares of Cellectar Biosciences within the last three months. Most recently, on Wednesday, July 2nd, Jarrod Longcor bought 10,000 shares of Cellectar Biosciences stock. The stock was acquired at an average cost of $4.99 per share, with a total value of $49,900.00. Following the completion of the transaction, the chief operating officer now directly owns 12,768 shares of the company's stock, valued at $63,712.32. Learn More on Jarrod Longcor's trading history.
Are insiders buying or selling shares of Cellectar Biosciences?: In the last twelve months, Cellectar Biosciences insiders bought shares 4 times. They purchased a total of 26,000 shares worth more than $133,150.00. The most recent insider tranaction occured on July, 2nd when COO Jarrod Longcor bought 10,000 shares worth more than $49,900.00. Insiders at Cellectar Biosciences own 5.0% of the company. Learn More about insider trades at Cellectar Biosciences.
Information on this page was last updated on 7/2/2025.

Jarrod Longcor Insider Trading History at Cellectar Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/2/2025	Buy	10,000	$4.99	$49,900.00	12,768
1/10/2025	Buy	1,000	$8.40	$8,400.00	2,771
12/28/2020	Buy	987	$40.50	$39,973.50	3,404
6/5/2020	Buy	2,173	$34.50	$74,968.50	2,417
2/28/2019	Buy	3	$60.00	$180.00	243
8/16/2018	Buy	16	$81.30	$1,300.80	240
3/13/2018	Sell	433	$35.40	$15,328.20	2,233

Jarrod Longcor Buying and Selling Activity at Cellectar Biosciences

Cellectar Biosciences Company Overview

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.

Today's Range

Now: $3.80

$3.61

$3.83

50 Day Range

MA: $3.99

$2.82

$6.17

2 Week Range

Now: $3.80

$2.71

$44.70

Volume

14,102 shs

Average Volume

68,389 shs

Market Capitalization

$16.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.47

Jarrod Longcor Biography and Net Worth

What is Jarrod Longcor's net worth?

How old is Jarrod Longcor?

What is Jarrod Longcor's salary?

How do I contact Jarrod Longcor?

Has Jarrod Longcor been buying or selling shares of Cellectar Biosciences?

Are insiders buying or selling shares of Cellectar Biosciences?